Clinical Trials › NCT04699747
RecruitingPhase 1
Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects
Sponsored by Massachusetts General Hospital
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 60
Target enrollment
1
U.S. states
Mar 2021
Start date
Nov 2026
Expected completion
Interventions / Treatments
F-18 3F4AP
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Massachusetts1 site
Boston
Participating MS centers on MS Buddy (1)
Massachusetts General Hospital MS Clinic
Boston, MA
Boston, MA
MS centers in Massachusetts
Compare treatment centers near a trial site by center type, providers and trials.
View Massachusetts centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.